Applied first-line systemic treatments, treatment modifications and outcomes in non-oncogenic metastatic non-small cell lung cancer in the Netherlands in 2019–2020: A nationwide study
Best supportive care over systemic treatment and chemotherapy treatment modifications are common in patients with mNSCLC. Presenting information to patients about these outcomes can support shared-decision making.
Authors
- E.M.W. van de Garde (ORCID: https://orcid.org/0000-0002-1334-2144)
- Natalie D. Veen
- J.W. Ankersmid-Matos Miguel
- Cornelia F. van Uden–Kraan (ORCID: https://orcid.org/0000-0002-3898-416X)
- Ronald Damhuis (ORCID: https://orcid.org/0000-0001-7248-7047)
- William Jacobs
Institutions
- St. Antonius Ziekenhuis (NL)
- Martini Ziekenhuis (NL)
- Pharmo Institute (NL)
- Santeon (Netherlands) (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.canep.2025.102809
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- KWF Kankerbestrijding